Additional information
| Active substance | Fluoxetine |
|---|---|
| Water Retention | Minimal |
| Hepatotoxicity | Low risk, but liver function tests are recommended during prolonged use |
| Lab Test | Monitoring plasma levels is not routinely required but can be done if overdose is suspected or for pharmacokinetic studies |
| Strength | 20 mg |
| Also known as | Prozac, fluoxetine hydrochloride |
| Blood pressure | Typically has minimal effect on blood pressure |
| Trade name | Prozac, Sarafem, among others |
| Storage conditions | Store at room temperature, away from moisture and heat |
| Chemical name | (RS)-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine |
| Formula | C17H18F3NO |
| Substance class | Selective Serotonin Reuptake Inhibitor (SSRI) |
| Main action | Inhibits the reuptake of serotonin in the brain |
| Half-life | 1 to 3 days for fluoxetine and 4 to 6 days for its active metabolite, norfluoxetine |
| Dosage (medical) | Typically 20 mg per day, may be adjusted based on response and tolerability |
| Dosage (sports) | Not applicable as it is not used to enhance athletic performance |
| Effects | Antidepressant, improves mood, sleep, appetite, and energy level |
| Side effects | Nausea, headache, dizziness, dry mouth, sweating, sleep disturbances, sexual dysfunction |
| Use in sports | None, as it does not enhance athletic performance |
| Manufacturer | Cadila Pharmaceuticals Ltd. |
| Packing | 15 caps/blister |
Reviews
There are no reviews yet.